Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BLTE | RYTM | KYMR | ||
| Company | Belite Bio Inc ADR | Rhythm Pharmaceuticals Inc | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 176.46 | 101.56 | 84.54 | ||
| High | 180.45 | 103.50 | 86.54 | ||
| Low | 172.80 | 99.21 | 82.48 | ||
| Latest | 179.77 | 103.16 | 86.50 | ||
| Change | +5.86 | +1.86 | +1.39 | ||
| % Change | +3.37% | +1.84% | +1.63% | ||
| Volume | 167,900 | 611,400 | 557,600 | ||
| 20-Day Average Volume | 211,305 | 643,725 | 760,810 | ||
| Previous Close | 173.91 | 101.30 | 85.11 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.09 | 103.41 | 77.67 | ||
| 20-Day Raw Stochastic | 53.48% | 48.83% | 90.55% | ||
| 20-Day Relative Strength | 60.60 | 49.14 | 63.71 | ||
| Weighted Alpha | +255.63 | +52.68 | +79.03 | ||
| Today's Opinion | 100% Buy | 8% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 8% Sell | 88% Buy | ||
| Last Month's Opinion | 96% Buy | 48% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.69% since 02/11/26 | +4.76% since 02/11/26 | +5.14% since 02/11/26 | ||
| Low | 171.00 on 02/18/26 | 95.44 on 02/13/26 | 80.36 on 02/17/26 | ||
| High | 180.45 on 02/19/26 | 104.50 on 02/17/26 | 88.40 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | +15.90% since 01/16/26 | +1.51% since 01/16/26 | +24.39% since 01/16/26 | ||
| Low | 150.00 on 01/20/26 | 95.44 on 02/13/26 | 66.21 on 01/20/26 | ||
| High | 200.00 on 02/03/26 | 111.25 on 02/03/26 | 88.40 on 02/18/26 | ||
| 3-Month | |||||
| %Chg | +49.35% since 11/19/25 | +0.01% since 11/19/25 | +33.45% since 11/19/25 | ||
| Low | 105.88 on 11/20/25 | 95.44 on 02/13/26 | 63.69 on 12/02/25 | ||
| High | 200.00 on 02/03/26 | 122.20 on 12/11/25 | 103.00 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +190.84% since 08/19/25 | +6.14% since 08/19/25 | +103.19% since 08/19/25 | ||
| Low | 60.00 on 08/20/25 | 94.39 on 09/15/25 | 39.84 on 09/02/25 | ||
| High | 200.00 on 02/03/26 | 122.20 on 12/11/25 | 103.00 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,524,233 | 6,760,357 | 6,123,579 | ||
| Shares Outstanding, K | 37,515 | 66,736 | 71,949 | ||
| Annual Sales | 0 | 130,130,000 | 47,070,000 | ||
| Annual Net Income | -36,140,000 | -260,600,000 | -223,860,000 | ||
| Last Quarter Sales | 0 | 51,300,000 | 2,760,000 | ||
| Last Quarter Net Income | -21,690,000 | -52,900,000 | -82,180,000 | ||
| 60-Month Beta | -1.46 | 2.00 | 2.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.65 on 11/10/25 | -0.82 on 11/04/25 | -0.90 on 11/04/25 | ||
| Latest Earnings Date | 03/16/26 | 02/26/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||